
Bonum Therapeutics
Bonum Therapeutics is a biotechnology company developing a novel class of regulated and targeted protein therapeutics for the treatment of cancer and other diseases.
/10
Transparency ranking
Work at Bonum Therapeutics?
Tell us what we're missing about working at Bonum Therapeutics so we can make the job search more transparent for everyone.
Tell us what it's like to work at Bonum Therapeutics!Description
Bonum Therapeutics is a Seattle-based biotechnology company developing a novel class of context-dependent therapeutics that are only active when bound to a target molecule. Their technology platform utilizes a shape-shifting mechanism, based on antibody binding, to create drugs that are inactive in circulation but become active in the presence of a specific target. This approach aims to maximize patient benefit by delivering potent biological activity only where needed, leading to safer and more effective treatments.
Bonum's current pipeline focuses on the treatment of cancer, with programs targeting immune cells and other cell types within the tumor microenvironment. They are also exploring potential applications in areas like autoimmune disease, metabolic disorders, and pain management. Bonum was formed after the acquisition of their predecessor company, Good Therapeutics, by Roche in 2022, and they have secured a $93 million Series A financing to advance their novel therapies.
Benefits
Bonum Therapeutics offers competitive salaries, excellent benefits, and generous equity participation. They also emphasize a supportive, fun, and family-friendly work environment.
Mission
Bonum Therapeutics is dedicated to developing a new class of highly targeted and conditionally active therapeutics that deliver potent biological activity only where needed. Their mission is to harness and direct the power of fundamental biological pathways in a targeted manner, maximizing patient benefit while simultaneously improving safety. They believe this approach will result in treatments with improved efficacy, decreased toxicity, and an expanded potential for combination with other therapies.
Culture
Bonum Therapeutics cultivates a supportive, fun, and family-friendly environment that prioritizes diversity of background, perspective, and expertise. They value innovation and encourage a hands-on, iterative approach to building and testing new molecules. Their culture emphasizes teamwork, collaboration, and a "no jerks" approach to hiring, ensuring a positive and engaging work experience for all employees.
DE&I
Bonum Therapeutics values diversity in background, perspective, and expertise, and actively seeks to build a supportive, fun, and family-friendly work environment. They encourage applications from a broad range of qualified individuals and explicitly state that they do not work with recruiters, valuing direct applicants.
Similar companies. But verified.
